SG Americas Securities
XBIT icon

SG Americas Securities’s XBiotech XBIT Stock Holding History

SG Americas Securities’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-12,735
Closed -$165K – 3858
2021
Q3 		$165K Buy
+12,735
New +$203K ﹤0.01% 3358
2017
Q2 		– Sell
-7,363
Closed -$121K – 3571
2017
Q1 		$121K Sell
7,363
-4,491
-38% -$58.8K ﹤0.01% 2851
2016
Q4 		$120K Buy
+11,854
New +$158K ﹤0.01% 2742

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

SG Americas Securities's XBIT Position: Q4 2021 in Review

SG Americas Securities sold out of XBiotech (XBIT) in Q4 2021, closing a stake of 12,735 shares — an estimated $165K sold.

SG Americas Securities first reported a position in XBIT in Q4 2016 and held it in 3 quarters. The position peaked at $165K in Q3 2021. 61 funds tracked by Wall St. Rank hold XBIT as of Q4 2021.

  • SG Americas Securities reported no remaining XBiotech position as of Q4 2021 after selling out during the quarter.
  • SG Americas Securities sold 12,735 XBiotech shares in Q4 2021, an estimated $165K.
  • SG Americas Securities first reported a position in XBiotech in Q4 2016 and held it in 3 quarters.
  • SG Americas Securities's XBiotech position peaked at $165K in Q3 2021.
  • 61 funds tracked by Wall St. Rank held XBiotech as of Q4 2021.

Based on SG Americas Securities's 13F filing for Q4 2021, filed 7 Feb 2022.